- Home
- STNG vs VERA Comparison
STNG vs VERA Comparison
Compare STNG & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STNG
- VERA
- Stock Information
- Founded
- STNG 2009
- VERA 2016
- Country
- STNG Monaco
- VERA United States
- Employees
- STNG N/A
- VERA N/A
- Industry
- STNG Marine Transportation
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- STNG Consumer Discretionary
- VERA Health Care
- Exchange
- STNG Nasdaq
- VERA Nasdaq
- Market Cap
- STNG 2.3B
- VERA 2.0B
- IPO Year
- STNG 2010
- VERA 2021
- Fundamental
- Price
- STNG $44.32
- VERA $20.92
- Analyst Decision
- STNG Buy
- VERA Buy
- Analyst Count
- STNG 4
- VERA 8
- Target Price
- STNG $60.50
- VERA $64.63
- AVG Volume (30 Days)
- STNG 763.3K
- VERA 2.9M
- Earning Date
- STNG 07-29-2025
- VERA 08-07-2025
- Dividend Yield
- STNG 3.61%
- VERA N/A
- EPS Growth
- STNG N/A
- VERA N/A
- EPS
- STNG 10.31
- VERA N/A
- Revenue
- STNG $1,066,599,000.00
- VERA N/A
- Revenue This Year
- STNG N/A
- VERA N/A
- Revenue Next Year
- STNG $1.73
- VERA N/A
- P/E Ratio
- STNG $4.30
- VERA N/A
- Revenue Growth
- STNG N/A
- VERA N/A
- 52 Week Low
- STNG $30.63
- VERA $18.53
- 52 Week High
- STNG $84.67
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- STNG 65.60
- VERA 43.81
- Support Level
- STNG $41.16
- VERA $21.64
- Resistance Level
- STNG $40.51
- VERA $23.14
- Average True Range (ATR)
- STNG 1.56
- VERA 1.73
- MACD
- STNG 0.38
- VERA -0.44
- Stochastic Oscillator
- STNG 90.79
- VERA 14.99
About STNG Scorpio Tankers Inc.
Scorpio Tankers Inc is a provider of marine transportation of petroleum products. It owns, lease finances or bareboat charters in hundred ten product tankers namely thirty nine LR2 tankers, fifty seven MR tankers and forteeen Handymax tankers. The company's fleet of tankers is the largest, most eco-friendly and newest fleet on the water hauling clean petroleum products. They provide seaborne transportation of crude oil and refined petroleum products worldwide. The company generates majority of its revenue from MR vessel.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.